Table 5.
HCRU in mild-to-moderate AD patients compared with matched non-AD controls
Variable | Mean (SD) number per patient [Low 95% CI – High 95% CI] |
||
---|---|---|---|
Mild-to-moderate AD patients | Matched non-AD control patientsb | p-value | |
GP visits | 5.57 (0.04) [5.49–5.66] | 3.59 (0.04) [3.50–3.67] | < 0.0001 |
Total referrals | 0.97 (0.02) [0.94–1.00] | 0.82 (0.02) [0.79–0.85] | < 0.0001 |
Mean non-AD related dermatology referralsa | 0.03 (0.00) [0.029–0.036] | 0.01 (0.00) [0.003–0.010] | < 0.0001 |
AD-related prescriptions | 5.85 (0.05) [5.74–5.95] | 0.68 (0.05) [0.580–0.786] | < 0.0001 |
AD atopic dermatitis, CI confidence Intervals, GP general practitioner, HCRU healthcare resource utilisation, SD standard deviations, THIN The Health Improvement Network
aReferrals to an outpatient clinic or hospital
bAD patients were propensity score matched with up to three non-AD controls based on demographics including age, sex, socio-economic status and practice ID